According to the CITIC Construction Investment Securities Research Report, the 2026 edition of the basic drug catalogue showed three major characteristics: First, the total number of varieties increased from 685 to 794 in the 2018 edition, 476 types of chemicals and biological products, and 318 types of proprietary Chinese medicines. The proportion of proprietary Chinese medicines increased to about 40%. Second, 16 new innovative drugs have been added to fully support the development of innovative pharmaceutical companies in China, while expanding the types of drugs at the grass-roots level; third, adhering to the principle of equal emphasis on traditional Chinese and Western medicine and the combined use of Chinese and Western medicines, 48 new proprietary Chinese medicines have been added. In addition to basically covering the clinical branches of traditional Chinese medicine, the new traditional Chinese medicine types mainly focus on the dominant diseases of traditional Chinese medicine, such as those used in diseases related to the heart, lung system, brain system, gynecology, etc., and special pediatric drugs. CITIC Construction Investment believes that the 2026 basic drug catalogue adjustment results send a positive signal: the number of varieties in the basic drug catalogue continues to expand, and the number of innovative drug types included is rising, reflecting the full support of the basic drug catalogue adjustment for the development of innovative drugs, and the efficiency of medical insurance entry for innovative drugs is expected to further improve.

According to the CITIC Construction Investment Securities Research Report, the 2026 edition of the basic drug catalogue showed three major characteristics: First, the total number of varieties increased from 685 to 794 in the 2018 edition, 476 types of chemicals and biological products, and 318 types of proprietary Chinese medicines. The proportion of proprietary Chinese medicines increased to about 40%. Second, 16 new innovative drugs have been added to fully support the development of innovative pharmaceutical companies in China, while expanding the types of drugs at the grass-roots level; third, adhering to the principle of equal emphasis on traditional Chinese and Western medicine and the combined use of Chinese and Western medicines, 48 new proprietary Chinese medicines have been added. In addition to basically covering the clinical branches of traditional Chinese medicine, the new traditional Chinese medicine types mainly focus on the dominant diseases of traditional Chinese medicine, such as those used in diseases related to the heart, lung system, brain system, gynecology, etc., and special pediatric drugs. CITIC Construction Investment believes that the 2026 basic drug catalogue adjustment results send a positive signal: the number of varieties in the basic drug catalogue continues to expand, and the number of innovative drug types included is rising, reflecting the full support of the basic drug catalogue adjustment for the development of innovative drugs, and the efficiency of medical insurance entry for innovative drugs is expected to further improve.